HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Up 42.7% in July
HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Up 42.7% in July
HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the target of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 41,800 shares, a growth of 42.7% from the July 15th total of 29,300 shares. Based on an average daily volume of 78,500 shares, the short-interest ratio is currently 0.5 days.
HAvn Life Science Inc.(OTCMKTS：HAVLF-GET Rating)是7月份空头股数大幅增长的目标。截至7月31日，空头股数共有4.18万股，比7月15日的2.93万股增长了42.7%。以日均成交量78,500股计算，目前短息比率为0.5天。
HAVN Life Sciences Stock Performance
有生命科学类股表现
OTCMKTS:HAVLF traded up $0.08 during mid-day trading on Friday, hitting $0.87. 711 shares of the company traded hands, compared to its average volume of 80,966. HAVN Life Sciences has a one year low of $0.03 and a one year high of $0.34. The stock's fifty day moving average price is $1.21 and its 200-day moving average price is $1.73.
OTCMKTS：HAVLF在周五午盘交易中上涨0.08美元，触及0.87美元。该公司711股易手，而其平均成交量为80,966股。HAvn Life Sciences的一年低点为0.03美元，一年高位为0.34美元。该股的50日移动均线价格为1.21美元，200日移动均线价格为1.73美元。
About HAVN Life Sciences
关于HAVN生命科学
(Get Rating)
(获取评级)
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- 2 Important Retail Stock Battles to Watch
- MarketBeat: Week in Review 8/8 – 8/12
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
- 免费获取StockNews.com关于HAVN生命科学的研究报告(HAVLF)
- 值得关注的两场重要的零售股大战
- MarketBeat：回顾中的一周2012-8-8
- 什么是WallStreetBets，他们的目标是什么股票？
- 机构和分析师推动Jack in the Box走高
- 你能猜到哪个电动车股票打败了特斯拉吗？
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
接受《HAVN生命科学日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对HAVN生命科学和相关公司的最新新闻和分析师评级的每日简要摘要。